Since 1997, VESALE Pharma has established a comprehensive development plan and increased investment in R & D in its different therapeutic areas, with particular focus on probiotics. Research programs pursue a major goal: to develop new effective and safe health products and innovative dosage based on major health needs or welfare who have not yet found satisfactory answers.
Supporting men and women throughout their lives, preserving their health and well being by offering them innovative solutions – this is the mission of the Belgian pharmaceutical company, Vésale Pharma. A pioneer in the probiotic area, in 1996 Vésale Pharma introduced the first probiotic to the Belgian market: Bacilac, developed in cooperation with the University of Liege. This insistence on quality has recently been recognised with the award of a quality label by the European Scientific League for Probiotics (ESLP). Vésale Pharma is active in more than 40 countries world-wide with a range of products exclusively available in pharmacies.